Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Prothrombin complex concentrate (PCC), also known as factor IX complex, sold under the brand name Kcentra among others, is a combination medication made up of blood clotting factors II, IX, and X(3-factor PCC) or, when also containing factor VII as does Kcentra, 4-factor PCC. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is…
History & Applications
Explore the main themes, entities and connections around Prothrombin complex concentrate. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
prothrombin complex concentrate factor ix may also used blood clotting factors hemophilia bleeding available effects include warfarin ii vii pcc
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Prothrombin complex concentrate | AHFS/Drugs.com | Monograph Monograph | 1.00 | infobox |
| Prothrombin complex concentrate | ATC code | B02BD01 (WHO) B02BD04 (WHO) | 1.00 | infobox |
| Prothrombin complex concentrate | CAS Number | 37224-63-8 Y | 1.00 | infobox |
| Prothrombin complex concentrate | DrugBank | DB11330 | 1.00 | infobox |
| Prothrombin complex concentrate | DrugBank | DB13152 | 1.00 | infobox |
| Prothrombin complex concentrate | Factor II | Blood clotting factor | 1.00 | infobox |
| Prothrombin complex concentrate | Factor IX | Blood clotting factor | 1.00 | infobox |
| Prothrombin complex concentrate | Factor VII | Blood clotting factor | 1.00 | infobox |
| Prothrombin complex concentrate | Factor X | Blood clotting factor | 1.00 | infobox |
| Prothrombin complex concentrate | Legal status | CA: ℞-only | 1.00 | infobox |
| Prothrombin complex concentrate | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Prothrombin complex concentrate | Legal status | US: ℞-only | 1.00 | infobox |
| Prothrombin complex concentrate | Legal status | EU: Rx-only | 1.00 | infobox |
| Prothrombin complex concentrate | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Prothrombin complex concentrate | License data | US DailyMed: Kcentra | 1.00 | infobox |
| Prothrombin complex concentrate | Other names | factor IX complex | 1.00 | infobox |
| Prothrombin complex concentrate | Routes of administration | Intravenous | 1.00 | infobox |
| Prothrombin complex concentrate | Trade names | Kcentra, others | 1.00 | infobox |
| Prothrombin complex concentrate | UNII | RZ22DI43TP | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.